메뉴 건너뛰기
Oscotec Inc.
Translating science into medicine
로그인 유지
ID/PW 찾기
회원가입
로그인
회원가입
로그인
HOME
COMPANY
About Us
History
Members
Contact Us
PIPELINE
Pipeline Overview
Rheumatoid arthritis
Immune thrombocytopenia
Acute myeloid leukemia
Non-small cell lung cancer
Alzheimer's disease
NEWSROOM
Notice
Press Releases
Publications
IR Materials
Shareholder Notice
PRESS
주주님들께 드리는 글
2022.08.30
SCI Journal - SKI-G-8...
2022.02.16
FLT3/AXL Inhibitor (A...
2020.06.22
HOME
COMPANY
About Us
History
Members
Contact Us
PIPELINE
Pipeline Overview
Rheumatoid arthritis
Immune thrombocytopenia
Acute myeloid leukemia
Non-small cell lung cancer
Alzheimer's disease
NEWSROOM
Notice
Press Releases
Publications
IR Materials
Shareholder Notice
×
WELCOME
로그인 유지
ID/PW 찾기
×
LANGUAGE : 한국어
English
NEWSROOM
Notice
Press Releases
Publications
IR Materials
Notice
Press Releases
Publications
IR Materials
NEWSROOM
- Notice
- Press Releases
- Publications
- IR Materials
Home
NEWSROOM
Press Releases
T
기본글꼴
기본글꼴
✔
나눔고딕
✔
맑은고딕
✔
돋움
✔
✔
사이트를 뷰어로 보기
검색
Write
Title+내용
Title
내용
Comment
이름
닉네임
아이디
태그
검색
List
Zine
Gallery
List of Articles
Date
Site
Media
Pipeline
2018-06-11
Yuhan ups investment in biotechs for immuno-oncology drug push
THE INVESTOR
Yuhan/Lazertinib
2019-12-12
Yuhan to start phase-3 trial on lung cancer drug Lazertinib
KBR (; Korea Biomedical Review)
Lazertinib
2007-02-19
Profiles of Four New Stock-Billionaires
MBN
Oscotec
2021-03-02
Other news to note for March 2, 2021
BioWorld
Oscotec
2024-02-23
Oscotec/ADEL Initiates First-in-Human Dosing in Ph1 of Anti-MTBR Tau Antibody ADEL-Y01 In Alzheimer's Disease
yahoo! finance
Oscotec
2023-09-14
Oscotec/ADEL Announce FDA Clearance of IND Application of ADEL-Y01 for the Treatment of Alzheimer's Disease
Biospace
Oscotec
2016-01-19
Oscotec`s SYK inhibitor Program Gets Korea Drug Fund Money
Scrip (Informa Pharma Intelligence)
SYK-O-703
2018-11-23
Oscotec`s acute leukemia treatment wins orphan drug status from FDA
KBR (; Korea Biomedical Review)
SKI-G-801
2019-06-25
Oscotec wins exception policy for continued R&D for new drugs
KBR (; Korea Biomedical Review)
Oscotec
2017-12-11
Oscotec shares rebound on launch of US clinical trial
KBR (; Korea Biomedical Review)
SKI-G-801
2021-03-02
Oscotec and Beactica Therapeutics announce license and collaboration agreement to develop new cancer drug
CISION
Oscotec
2018-03-14
More than half of Korean biopharma firms view R&D investments as assets.
The Korea Herald
Industry
Board Pagination
Prev
1
2
3
Next
/ 3
GO
© k2s0o1d6e0s8i2g7n. ALL RIGHTS RESERVED.
서버에 요청 중입니다. 잠시만 기다려 주십시오...